Important Notice: the following excerpts are not designed to be standalone summaries and as such, important information may be missing from these samples. Please download the entire research report, free of charge, to ensure you are reading all relevant material information. All information in this release was accessed May 11th, 2018. Percentage calculations are performed after rounding. All amounts in millions (MM), except per share amounts.

For the three months ended January 31st, 2018 vs January 31st, 2017, Advaxis reported revenue of $2.06MM vs $3.79MM (down 45.77%) and basic earnings per share -$0.49 vs -$0.43. For the twelve months ended October 31st, 2017 vs October 31st, 2016, Advaxis reported revenue of $12.03MM vs $3.99MM (up 201.16%) and basic earnings per share -$2.31 vs -$2.08. Advaxis is expected to report earnings on June 5th, 2018. The report will be for the fiscal period ending April 30th, 2018. The reported EPS for the same quarter last year was -$0.51.

For the three months ended March 31st, 2018 vs March 31st, 2017, e.l.f. Beauty reported revenue of $65.92MM vs $60.57MM (up 8.83%) and basic earnings per share $0.01 vs $0.05 (down 80.00%). For the twelve months ended December 31st, 2017 vs December 31st, 2016, e.l.f. Beauty reported revenue of $269.89MM vs $229.57MM (up 17.56%) and basic earnings per share $0.74 vs -$39.47. e.l.f. Beauty is expected to report earnings on August 8th, 2018. The report will be for the fiscal period ending June 30th, 2018. The reported EPS for the same quarter last year was $0.08. The estimated EPS forecast for the next fiscal year is $0.51 and is expected to report on February 26th, 2019.

For the three months ended March 31st, 2018 vs March 31st, 2017, Heron Therapeutics reported revenue of $11.57MM vs $3.63MM (up 218.47%) and basic earnings per share -$0.81 vs -$1.00. For the twelve months ended December 31st, 2017 vs December 31st, 2016, Heron Therapeutics reported revenue of $30.77MM vs $1.28MM (up 2,305.55%) and basic earnings per share -$3.65 vs -$4.56. Heron Therapeutics is expected to report earnings on August 8th, 2018. The report will be for the fiscal period ending June 30th, 2018. The reported EPS for the same quarter last year was -$0.80. The estimated EPS forecast for the next fiscal year is -$0.79 and is expected to report on February 26th, 2019.

For the three months ended January 31st, 2018 vs January 31st, 2017, PVH reported revenue of $2,498.90MM vs $2,107.70MM (up 18.56%) and basic earnings per share $1.40 vs $1.29 (up 8.53%). For the twelve months ended January 31st, 2018 vs January 31st, 2017, PVH reported revenue of $8,914.80MM vs $8,203.10MM (up 8.68%) and basic earnings per share $6.93 vs $6.84 (up 1.32%). PVH is expected to report earnings on May 23rd, 2018. The report will be for the fiscal period ending April 30th, 2018. The reported EPS for the same quarter last year was $1.65. The estimated EPS forecast for the next fiscal year is $10.47 and is expected to report on March 27th, 2019.

For the three months ended March 31st, 2018 vs March 31st, 2017, Energy Recovery reported revenue of $13.81MM vs $14.49MM (down 4.73%) and basic earnings per share -$0.01 vs $0.01. For the twelve months ended December 31st, 2017 vs December 31st, 2016, Energy Recovery reported revenue of $63.16MM vs $54.72MM (up 15.43%) and basic earnings per share $0.23 vs $0.02 (up 1,050.00%). Energy Recovery is expected to report earnings on August 1st, 2018. The report will be for the fiscal period ending June 30th, 2018. The reported EPS for the same quarter last year was -$0.01. The estimated EPS forecast for the next fiscal year is $0.42 and is expected to report on March 6th, 2019.

For the three months ended March 31st, 2018 vs March 31st, 2017, A. O. Smith reported revenue of $788.00MM vs $740.00MM (up 6.49%) and basic earnings per share $0.58 vs $0.51 (up 13.73%). For the twelve months ended December 31st, 2017 vs December 31st, 2016, A. O. Smith reported revenue of $2,996.70MM vs $2,685.90MM (up 11.57%) and basic earnings per share $1.72 vs $1.87 (down 8.02%). A. O. Smith is expected to report earnings on July 25th, 2018. The report will be for the fiscal period ending June 30th, 2018. The reported EPS for the same quarter last year was $0.53. The estimated EPS forecast for the next fiscal year is $2.92 and is expected to report on January 29th, 2019.

Fundamental Markets serves thousands of members and have provided research through some of the world's leading brokerages for over a decade–and continue to be one of the best information sources for investors and investment professionals worldwide. Fundamental Markets' roster boasts decades of financial experience and includes top financial writers, FINRA® BrokerCheck® certified professionals with current and valid CRD® number designations, as well as Chartered Financial Analyst® (CFA®) designation holders, to ensure up to date factual information for active readers on the topics they care about.

Fundamental Markets' oversight and audit staff are registered analysts, brokers, and/or financial advisers ("Registered Members") working within Equity Research, Media, and Compliance departments. Fundamental Markets' roster includes qualified CFA® charterholders, licensed securities attorneys, and registered FINRA® members holding duly issued CRD® numbers. Current licensed status of several Registered Members at Fundamental Markets have been independently verified by an outside audit firm, including policy and audit records duly executed by Registered Members. Complaints, concerns, questions, or inquiries regarding this release should be directed to Fundamental Markets' Compliance department by Phone, at +1 667-401-0010, or by E-mail at [email protected].

Information contained herein is not an offer or solicitation to buy, hold, or sell any security. Fundamental Markets, Fundamental Markets members, and/or Fundamental Markets affiliates are not responsible for any gains or losses that result from the opinions expressed. Fundamental Markets makes no representations as to the completeness, accuracy, or timeliness of the material provided and all materials are subject to change without notice. Fundamental Markets has not been compensated for the publication of this press release by any of the above mentioned companies. Fundamental Markets is not a financial advisory firm, investment adviser, or broker-dealer, and does not undertake any activities that would require such registration. For our full disclaimer, disclosure, and terms of service please visit our website.